LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 209 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2018$1,0000.0%5000.0%0.00%
Q2 2018$1,0000.0%5000.0%0.00%
Q1 2018$1,0000.0%5000.0%0.00%
Q4 2017$1,000
-50.0%
5000.0%0.00%
Q3 2017$2,000
+100.0%
5000.0%0.00%
Q2 2017$1,0000.0%5000.0%0.00%
Q1 2017$1,0000.0%5000.0%0.00%
Q4 2016$1,000
-50.0%
5000.0%0.00%
Q3 2016$2,0000.0%5000.0%0.00%
Q2 2016$2,0000.0%5000.0%0.00%
Q1 2016$2,0000.0%5000.0%0.00%
Q4 2015$2,000
-33.3%
5000.0%0.00%
Q3 2015$3,0000.0%5000.0%0.00%
Q2 2015$3,000
-25.0%
5000.0%0.00%
Q1 2015$4,000
-50.0%
500
-50.0%
0.00%
Q4 2014$8,000
+100.0%
1,000
+100.0%
0.00%
Q3 2014$4,000
-20.0%
5000.0%0.00%
Q2 2014$5,000
+25.0%
5000.0%0.00%
Q1 2014$4,0000.0%5000.0%0.00%
Q4 2013$4,0000.0%5000.0%0.00%
Q3 2013$4,0000.0%5000.0%0.00%
Q2 2013$4,0005000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 158,634$528,0000.73%
TFS CAPITAL LLC 795,409$2,649,0000.38%
Dynamic Capital Management Ltd 173,813$579,0000.22%
Acrospire Investment Management LLC 91,141$303,0000.21%
GSA CAPITAL PARTNERS LLP 905,024$3,014,0000.19%
RBF Capital, LLC 273,976$912,0000.18%
Gotham Asset Management, LLC 3,732,679$12,430,0000.14%
Advisors Asset Management, Inc. 2,362,054$7,866,0000.13%
A.R.T. Advisors, LLC 812,008$2,703,0000.12%
Bayesian Capital Management, LP 37,200$124,0000.12%
View complete list of PDL BIOPHARMA INC shareholders